Advaxis Must Face Claims Over 'Spring-Loaded' Stock Options
A Delaware Chancery judge kept clinical-stage cancer immunotherapy company Advaxis on the hook Tuesday for claims targeting so-called spring-loaded stock options that shot the value of some directors' compensation to roughly...To view the full article, register now.
Already a subscriber? Click here to view full article